KeyBanc sets $8 target on Rapid Micro Biosystems stock
KeyBanc Capital Markets has initiated coverage on Rapid Micro Biosystems Inc (NASDAQ:RPID) with an Overweight rating and a price target of $8.00. The new rating comes as KeyBanc analysts recognize the ...
Health companies return $2.6 trillion to shareholders over time amid rising medical costs
Consumers have grown accustomed to rising prices and red tape when filing a health insurance claim or filling a prescription. But for investors, health care has proven to be a lucrative industry to ...